The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia

The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia: the Development of Mobile Application System and Effectiveness Analysis

The object is to develop a training system of simultaneous walking and cognitive training for improving cognitive function of people with schizophrenia. The training program, called "Simultaneous Walk And Think for Cognitive Health mobile application software"(SWATCH App), is developed by researchers. A randomized controlled trial will be carried out to test the effectiveness of the training system. Ninety participants will be randomly assigned to: simultaneous training of walking and cognitive group, the cognitive training group, and treatment as usual group. The intervention for those groups will lasts for 12 weeks, with a 12 week of followup. The measurements include the cognitive function, physical fitness, and quality of life.

Study Overview

Detailed Description

Background: Schizophrenia is one of the severe mental disorders. In addition to psychiatric symptoms, cognitive impairment is a key clinical feature in this population, which significantly negatively influences their functional performance and independence. While the cognitive remediation therapy demonstrates positive results, it often involves specialized and expensive computerized cognitive training system, which limits its application in clinical setting. More evidence is available to support the benefits of exercise training on cognitive functions of schizophrenia. Combination of exercise and cognitive training is a promising program and can improve cognitive functions of the elderly. However, this combined therapy is still limited to schizophrenia. Simultaneous training of walking and cognitive tasks via auditory mobile application is an innovative program for saving cost, time, and manpower. Further study is needed to develop the simultaneous training program and to examine the effectiveness.

Purposes: To examine the effects of the training program on cognitive functions, fitness, functional performance and quality of life.

Methods: A 3-arm, single-blinded, randomized controlled trial is used to recruit 90 participants and then randomly allocated to the simultaneous training group, the cognitive training group, and the treatment as usual group. The first two training groups receive training for 30-40 minutes, 3 times a week for 12 weeks, as well as a follow-up of 12 weeks. All participants will be assessed at baseline, post-test and follow-up assessment. Primary outcome is cognitive function and secondary outcomes are fitness, functional performance, and quality of life.

Contribution: The study can be used as an evidence-based program to improve cognitive functioning of people with schizophrenia. With the development of mobile App and the use of fitness wearable device, the training program enables people with schizophrenia to walk and practice cognitive training simultaneously in a group format. It will help clinical professionals be able to serve the increasing number of people with severe mental illness with less manpower and specialized equipment. The study is also helpful to better understanding the isolated role of aerobic exercise in the dual-task training, and to apply to other groups, like the elderly or dementia.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kaohsiung, Taiwan
        • Ming-De Chen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Diagnosis of schizophrenia or schizoaffective disorder by a psychiatric clinician on the basis of the criteria set the Diagnostic and Statistical Manual of Mental Disorders 5th edition, DSM-5, has been more than 1 year.
  2. Age 20-60 years old.
  3. Living in daycare center or community-based mental health rehabilitation services or rehabilitation ward.
  4. Having stable psychiatric conditions (i.e., primary psychiatric medications had not changed for more than two months)
  5. The MATRICS Consensus Cognitive Battery (MCCB) (Nuechterlein et al., 2008) shows that at least one domain with cognitive impairment (below the value of -1SD).
  6. Can follow the research process and sign the consent form.

Exclusion Criteria:

  1. Traumatic brain injury and other neurological diseases, alcohol and substance abuse
  2. Pregnancy, cardiovascular disease, and unsuitable to exercise training due to physical movement difficulties
  3. According participants' self-report, having following conditions, including severe heart failure, myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, COPD, poor glycemic control (i.e., dialysis, diabetic neuropathy or retinopathy) and lower extremity arthritis
  4. Uncontrolled hypertension with SBP> 160 mmHg or DBP> 110 mmHg
  5. Diagnosis of intellectual disability
  6. Unconscious or confusion of consciousness
  7. Participating in other intervention studies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Simultaneous training of walking and cognitive group
  1. Wearable technology (fitness wristband & App)
  2. SWATCH system (App & controller)
  3. 3 times a week (30 mins/ each time)
  4. Lasts for 12 weeks
  5. Simultaneous walking and cognitive training

Device:

  1. SWATCH system (App & controller)
  2. Wearable technology Fitness wristband & APP
Active Comparator: Cognitive training group
  1. Wearable technology (fitness wristband & App)
  2. SWATCH system (App)
  3. 3 times a week (30 mins/ each time)
  4. Lasts for 12 weeks
  5. Cognitive training while sitting

Device:

  1. SWATCH system (App)
  2. Wearable technology Fitness wristband & APP
Active Comparator: Treatment as usual group
1. Keep treatment as usual group at health care system.
Keep treatment as usual

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive function
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

MATRICS Consensus Cognitive Battery: Traditional Chinese Version (MCCB) consists of 10 individually administered tests to measure cognitive performance in the following seven domains:

  1. Processing Speed

    1.1 Trail Making Test (TMT).

    1.2 Brief Assessment of Cognition in Schizophrenia: Symbol Coding (BACS SC).

    1.3 Category Fluency: Animal Naming (Fluency).

  2. Attention

    2.1 Continuous Performance Test: Identical Pairs (CPT-IP).

  3. Working memory

    3.1 Wechsler Memory Scale-III (WMS III): Spatial Span.

    3.2 Wechsler Letter: Number Sequencing (WAIS-III).

  4. Verbal Learning

    4.1 Hopkins Verbal Learning Test-Revised (HVLT-R).

  5. Visual Learning

    5.1 Brief Visuospatial Memory Test-Revised (BVMT-R).

  6. Reasoning and Problem Solving

    6.1 Neuropsychological Assessment Battery (NAB): Mazes.

  7. Social Cognition

7.1 Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT): Managing Emotions.

Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Using Body Mass Index (BMI) as the measurement of body composition, which weight and height will be combined to report BMI in kg/m^2.
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Cardiorespiratory fitness
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Using 6-minute walk test (6MWT) as the measurement, which let the participant walks as far as possible over a total of six minutes on hard and flat floor. And the researcher will measure the distance that participant walks in 6 minutes.
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Leg muscular strength and endurance
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Using 30-Second Sit to Stand Test. The participant will sit in the middle of the chair, and rise to a full standing position, then sit back down again. Repeat these movements for 30 seconds. And researcher will count the times.
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Balance and Agility
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
The Timed Up and Go test (TUG). It measures the time that the participant takes to rise from a chair, walk eight foots, turn around, walk back to the chair, and sit down.
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Dual-Task Performance Involving Hand Dexterity and Cognitive Tasks
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Dual-Task Performance Involving Hand Dexterity and Cognitive Tasks, this test is combine the Purdue Pegboard Test (PPT; Tiffin & Asher, 1948) and the Serial Sevens Subtraction Test (SSST; Manning, 1982), Purdue Pegboard Test use to measures hand dexterity; Serial Sevens Subtraction Test as a cognitive task for the dual-task condition.
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Instrumental Activity of Daily Living (IADL)
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Lawton and Brody Instrumental Activity of Daily Living Scale is a self-report survey. It is used to evaluate the degree of participant's instrumental activities. There are total 8 descriptions, the scale scores ranges is between 0 to 8. The higher values represent a better outcome.
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4)
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
Schizophrenia Quality of Life Scale Revision 4 is a self-report survey. It is used to evaluate the degree of participant's quality of life. There are total 33 items, the scale scores statements are rated 1 (never) to 5 (always). The higher values represent a better outcome.
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ming-De Chen, Ph.D., Department of Occupational Therapy, College of Health Sciences, Kaohsiung Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2019

Primary Completion (Actual)

July 7, 2021

Study Completion (Actual)

July 7, 2021

Study Registration Dates

First Submitted

October 18, 2019

First Submitted That Met QC Criteria

October 27, 2019

First Posted (Actual)

October 29, 2019

Study Record Updates

Last Update Posted (Actual)

June 21, 2024

Last Update Submitted That Met QC Criteria

June 19, 2024

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Simultaneous training of walking and cognitive group

Subscribe